Differential expression of matrix metalloproteinases in bacterial meningitis

被引:80
作者
Kieseier, BC
Paul, R
Koedel, U
Seifert, T
Clements, JM
Gearing, AJH
Pfister, HW
Hartung, HP
机构
[1] Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria
[2] Univ Munich, Dept Neurol, D-8000 Munich, Germany
[3] British Biotech Pharmaceut Ltd, Oxford, England
关键词
gelatinase B; collagenase-3; stromelysin-1; bacterial meningitis; experimental meningitis;
D O I
10.1093/brain/122.8.1579
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of various inflammatory diseases of the central nervous system. Evidence is accumulating that gelatinase B (MMP-9) might be involved in the pathogenesis of meningitis, but the spectrum of different MMPs involved in the inflammatory reaction of this disease has not been determined. We investigated the temporal and spatial mRNA expression pattern of gelatinase B in experimental meningococcal meningitis in rats. In contrast to controls, increased mRNA levels with peak values 6 h after injection with menigococci were found in brain specimens of the animals. Elevated MMP-9 mRNA expression was accompanied by enhanced proteolytic activity, as demonstrated by gelatin zymography, and positive immunoreactivity, The mRNA expression pattern of six other MMPs was investigated. Collagenase-3 and stromelysin-1 mRNAs were also found to be upregulated, In contrast, mRNA levels for gelatinase A, matrilysin, stromelysin-2 and stromelysin-3 remained unchanged. As evidenced by significantly increased intracranial pressure and by leakage of intravenously injected Evans blue through the blood vessel walls into the brain parenchyma, the animals injected with meningococci revealed signs of blood-brain barrier disruption. Augmented proteolytic activity of MMP-9 could also be demonstrated in CSF samples obtained from patients with bacterial meningitis, underlining the clinical relevance of our experimental findings. Our data indicate that gelatinase B, collagenase-3 and stromelysin-1 are selectively upregulated in bacterial meningitis and thus may contribute to the pathogenesis of this infectious disease of the central nervous system.
引用
收藏
页码:1579 / 1587
页数:9
相关论文
共 47 条
  • [1] The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications
    Archelos, JJ
    Hartung, HP
    [J]. MOLECULAR MEDICINE TODAY, 1997, 3 (07): : 310 - 321
  • [2] PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX
    BIRKEDALHANSEN, H
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) : 728 - 735
  • [3] A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
    Black, RA
    Rauch, CT
    Kozlosky, CJ
    Peschon, JJ
    Slack, JL
    Wolfson, MF
    Castner, BJ
    Stocking, KL
    Reddy, P
    Srinivasan, S
    Nelson, N
    Boiani, N
    Schooley, KA
    Gerhart, M
    Davis, R
    Fitzner, JN
    Johnson, RS
    Paxton, RJ
    March, CJ
    Cerretti, DP
    [J]. NATURE, 1997, 385 (6618) : 729 - 733
  • [4] BROWN PD, 1990, CANCER RES, V50, P6184
  • [5] Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases
    Cawson, T
    [J]. MOLECULAR MEDICINE TODAY, 1998, 4 (03): : 130 - 137
  • [6] PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES
    GEARING, AJH
    BECKETT, P
    CHRISTODOULOU, M
    CHURCHILL, M
    CLEMENTS, J
    DAVIDSON, AH
    DRUMMOND, AH
    GALLOWAY, WA
    GILBERT, R
    GORDON, JL
    LEBER, TM
    MANGAN, M
    MILLER, K
    NAYEE, P
    OWEN, K
    PATEL, S
    THOMAS, W
    WELLS, G
    WOOD, LM
    WOOLLEY, K
    [J]. NATURE, 1994, 370 (6490) : 555 - 557
  • [7] GELATINASE IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER INFLAMMATORY NEUROLOGICAL DISORDERS
    GIJBELS, K
    MASURE, S
    CARTON, H
    OPDENAKKER, G
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1992, 41 (01) : 29 - 34
  • [8] REVERSAL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH A HYDROXAMATE INHIBITOR OF MATRIX METALLOPROTEASES
    GIJBELS, K
    GALARDY, RE
    STEINMAN, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) : 2177 - 2182
  • [9] Goetzl EJ, 1996, J IMMUNOL, V156, P1
  • [10] GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513